Your browser doesn't support javascript.
loading
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose-expansion cohort.
Berdeja, Jesus G; Gregory, Tara K; Faber, Edward A; Hart, Lowell L; Mace, Joseph R; Arrowsmith, Edward R; Flinn, Ian W; Matous, Jeffrey V.
Afiliação
  • Berdeja JG; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Gregory TK; Tennessee Oncology PLLC, Nashville, Tennessee.
  • Faber EA; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Hart LL; Colorado Blood Cancer Institute, Denver, Colorado.
  • Mace JR; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Arrowsmith ER; Oncology Hematology Care, Cincinnati, Ohio.
  • Flinn IW; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Matous JV; Florida Cancer Specialists, Fort Myers, Florida.
Am J Hematol ; 96(4): 428-435, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33421178
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article